PETSULINA SPÓŁKA AKCYJNA

TAX ID5213654567

KRS0000475216

Share capital342,531.90 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. RABCZAŃSKA 31, 02-912 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

PETSULINA SPÓŁKA AKCYJNA

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. RABCZAŃSKA 31, 02-912 WARSZAWA

Show on map

NIP

5213654567

REGON

146853850

KRS

0000475216

Legal form

joint stock company

Register Address

UL. RABCZAŃSKA 31, 02-912 WARSZAWA

Date of registration in KRS

2013-08-30

Date of commencement of economic activity

2013-08-30

Act signature

WZNOW/11910/25/325

Pkd codes

46.46.Z - Wholesale trade of pharmaceutical and medical products

20.59.Z - Manufacture of other chemical products, not elsewhere classified

21.10.Z - Manufacture of basic pharmaceutical products

21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products

32.50.Z - Production of medical devices, instruments, and products, including dental products

46.75.Z - Wholesale trade

47.73.Z - Retail sale of pharmaceutical products

47.74.Z - Retail sale of medical and orthopedic products

72.19.Z - Scientific research and development activities

86.90.E - Healthcare

Company authorities

representation authorityMANAGEMENT

supervisory authorityboard of directors

representation type

DO SKŁADANIA OŚWIADCZEŃ WOLI I PODPISYWANIA W IMIENIU SPÓŁKI UPOWAŻNIONY JEST PREZES ZARZĄDU SAMODZIELNIE LUB DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE ALBO JEDEN CZŁONEK ZARZĄDU ŁĄCZNIE Z PROKURENTEM.

MANAGEMENT

Artur Chabowski

Chairman Of The Board, 57 years old

BOARD OF DIRECTORS

Marcin Obłuski

56 years old

Agnieszka Maja Sikorska Brzozowska

49 years old

Lynn Mason Moses

64 years old

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2018	2019
	K PLN	K PLN	%
Gross profit (loss)	-97,3	-5	94,8
EBITDA	-14,7	-5	65,9
Short time liabilities	6,8	7	2,6
Equity capital	401,3	347,8	-13,3
Operating profit (EBIT)	-95,2	-5	94,7
Assets	445,8	392,5	-11,9
Net profit (loss)	-84,2	-53,4	36,5
Cash	6,5	1,8	-72,6
Net income from sale	0,4	0	-100
Liabilities and provisions for liabilities	44,5	44,7	0,4
Working assets	50,1	45,3	-9,6
Depreciation	80,5	0	-100
	%	%	p.p.
Profitability of capital	-21	-15,4	5,6
Equity capital to total assets	90	88,6	-1,4
Gross profit margin	-24 322,2
EBITDA Margin	-3672,8
	Days	Days	Days
Short term commitment turnover cycle	6241	2 147 483 648	2 147 477 407

Current financial liquidity indicator	7.331267833709717	6.458673000335693	-0,8